The AUSMED Company is willing to expand its business in a foreign market. There are two countries where the company is willing to expand its business such as China or South Africa. The report provides a comparative analysis of the market situation of the two countries. Based on this analysis, the report also suggests the best country that the AUSMED Company should opt for and the market entry strategy for conducting its new business establishments.

MNG 00723 Assessment 2: Report

Prepare a report for AUSMED, an Australian pharma company, summarising the risks and opportunities in South Africa and China as potential expansion destinations, and recommend the best destination country and entry mode.

Report compares Chinese and South African pharmaceutical markets, recommends joint venture for company's entry into South Africa.

A Comparative Analysis of Chinese and South African Pharmaceutical Market

Global Business Assignment

This report evaluates the market opportunities and risks in the pharmaceutical industry of China and South Africa for AUSMED Company. It highlights the benefits of expanding in the Chinese market due to government reforms and increasing demand for healthcare medication. It also discusses the challenges in the South African market due to corruption and political mismanagement. The report suggests expanding in the Chinese market through partnership as the market entry strategy.

Healthcare and Research

Languages and Culture

Market Opportunities and Risks in Chinese and South African Pharmaceutical Industry

Labour Law

This paper focuses on the company AUSMED; an Australia based pharmaceutical company that has been facing issues because of their stagnation in terms of growth in the market. The company has been a successful company however this issue has made them take a decision of expanding in the foreign market in order to generate sales and improve their situation. The company has been considering South Africa and China for expansion to overcome this issue. This paper will assess the external environment of both the countries by conducting PESTEL analysis which will give an insight about the current market situation of the countries and which country will be more favorable for expansion. From the conducted analysis it has been seen that China is more favorable and entering the market with a joint venture will be feasible for AUSMED to establish them successfully and strive in the Chinese market and also help them in generating profits.

University of Cape Town

Finance

Economics

Political Science

Analysis of South Africa and China for Expansion of AUSMED

Global Business Management

This report discusses the potential risks and opportunities for both South Africa and China in relation to the pharmaceutical industry. The risks and opportunities will be critically analyzed based on different elements and factors. In accordance to the identified factors, the effective country will be selected. An ideal entry strategy will be identified that can help Ausmed to effectively enter in the target country.

Hartpury University and Hartpury College

This report analyzes the risks and opportunities of AUSMED's entry into the Chinese and South African markets, and proposes the best market and entry mode for each. The report discusses the challenges associated with market entry, the best strategy for entering a market, and the factors that should be considered when choosing a market. The report then analyzes the risks and opportunities of entering the Chinese and South African markets, and proposes the best market and entry mode for each. The report concludes by summarizing the findings and recommendations.

Leadership Management

Materials Science and Engineering

This report explores the opportunity for Ausmed, an Australian Pharma company, to expand their business operations in China and South Africa. The report includes an analysis of the risks and opportunities in both countries, selection of the country, and proposing and selecting market entry strategy. The report concludes that licensing will be a suitable mode of entry for the Ausmed, an Australian Pharma company.

Opportunities and Risks for Ausmed in Expanding Business Operations in China and South Africa

This document discusses the opportunities and risks for expanding business operations in South Africa and China. It analyzes the political, economic, social, technological, legal, and environmental factors in both countries. The report recommends China as the most suitable destination for expansion and suggests foreign direct investment as the proposed entry mode.

Global Business Assignment

Market Opportunities and Risks in Chinese and South African Pharmaceutical Industrylg...

Analysis of South Africa and China for Expansion of AUSMEDlg...

Global Business Managementlg...

Global Business Assignmentlg...

Opportunities and Risks for Ausmed in Expanding Business Operations in China and South Africalg...

Opportunities and Risks for Expansion in South Africa and Chinalg...

Market Opportunities and Risks in Chinese and South African Pharmaceutical Industry

Analysis of South Africa and China for Expansion of AUSMED

Global Business Management

Global Business Assignment

Opportunities and Risks for Ausmed in Expanding Business Operations in China and South Africa

Opportunities and Risks for Expansion in South Africa and China